17332526

Corbould A

2007

Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women.

17334586

Rajender S

2007

Phenotypic heterogeneity of mutations in androgen receptor gene.

17335818

Elnashar A

2007

N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study.

17335820

Chan TF

2007

Increased plasma visfatin concentrations in women with polycystic ovary syndrome.

17335955

Somunkiran A

2007

Anti-M?llerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.

17336970

Schachter M

2007

Prospective, randomized trial of metformin and vitamins for the reduction of plasma homocysteine in insulin-resistant polycystic ovary syndrome.

17336971

Holzer H

2007

In vitro maturation of oocytes collected from unstimulated ovaries for oocyte donation.

17336975

Unl?hizarci K

2007

Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome.

17336978

Romualdi D

2007

Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.

17341570

Webber LJ

2007

Prolonged survival in culture of preantral follicles from polycystic ovaries.

17342155

Barber TM

2007

Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.

17344003

Lin HC

2007

Lateral medullary syndrome in a woman after ovulation induction.

17344488

Kasim-Karakas SE

2007

Relation of nutrients and hormones in polycystic ovary syndrome.

17345847

Bana? M

2006

[The role of tumor necrosis factor and interleukin-6 in polycystic ovary syndrome].

17346715

Schattmann L

2007

Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study.

17347165

Lainas TG

2007

Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development.

17347533

Froment P

2006

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS).

17349600

McGill DJ

2007

Laser hair removal in women with polycystic ovary syndrome.

17350746

Seibel SA

2008

Effect of metformin on IGF-1 and IGFBP-1 levels in obese patients with polycystic ovary syndrome.

17353865

Diamanti-Kandarakis E

2007

Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.

17353867

Rizzo M

2007

Androgen excess and cardiovascular risk.

17353875

Orio F

2007

[Polycystic ovary syndrome and obesity: non pharmacological approaches].

17354203

Barber TM

2007

Metabolic syndrome in polycystic ovary syndrome.

17356050

Gambineri A

2007

Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.

17361532

Song JJ

2006

Progress of integrative Chinese and Western medicine in treating polycystic ovarian syndrome caused infertility.

17362862

Bonini S

2007

Itchy-dry eye associated with polycystic ovary syndrome.

17362944

Bahceci M

2007

Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.

17364275

Carlsen SM

2007

Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.

17364286

Badawy A

2007

N-Acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: a cross-over trial.

17366951

Ertorer ME

2007

A new perspective in diagnosing polycystic ovary syndrome.

17367220

Nazari T

2007

Metformin therapy in girls with polycystic ovary syndrome: a self-controlled clinical trial.

17367265

Glueck CJ

2007

Metformin before and during pregnancy and lactation in polycystic ovary syndrome.

17367914

Palep-Singh M

2007

South Asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadotropin stimulation with reduced fertilization and ongoing pregnancy rates than their Caucasian counterparts.

17368420

Vantyghem MC

2007

[11beta-hydroxysteroide dehydrogenases. Recent advances].

17368460

Li L

2007

Clinical and metabolic features of polycystic ovary syndrome.

17369295

Hu S

2007

Vascular dysfunction during pregnancy in women with polycystic ovary syndrome.

17370102

Saltamavros AD

2007

alpha 2 beta adrenoreceptor 301-303 deletion polymorphism in polycystic ovary syndrome.

17370489

Chen D

2007

[Clinical study on needle-pricking therapy for treatment of polycystic ovarial syndrome].

17371468

Barber TM

2007

Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.

17374431

Lowenstein L

2007

Evaluation of endothelial function in women with polycystic ovary syndrome.

17374711

Seto-Young D

2007

Interactions among peroxisome proliferator activated receptor-gamma, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells.

17388735

Talbott EO

2007

Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women.

17389256

Reckelhoff JF

2007

Polycystic ovary syndrome: androgens and hypertension.

17389259

Chen MJ

2007

Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.

17389441

Gagnon C

2007

Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome.

17389444

Lau DC

2007

Screening for diabetes in women with polycystic ovary syndrome.

17389696

Luque-Ram?rez M

2007

Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome.

17389770

Unluturk U

2007

The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.

17391092

Hutchison SK

2007

Insulin levels, insulin resistance and the use of metformin in polycystic ovary syndrome.

17391093

Lane SM

2007

We need guidelines for diagnosis and treatment of polycystic ovary syndrome.

17391095

Kidson WJ

2007

Insulin levels in polycystic ovary syndrome: a valuable tool.

17392600

Carmina E

2007

Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes.

17395684

Ludwig AK

2007

Influence of hypo- and hyperglycaemia on plasma leptin concentrations in healthy women and in women with polycystic ovary syndrome.

17397839

Hollinrake E

2007

Increased risk of depressive disorders in women with polycystic ovary syndrome.

17403434

Goodarzi MO

2007

Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters.

17403436

Legro RS

2007

The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.

17405838

Carmina E

2007

Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance.

17408014

Calvar CE

2007

[Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].

17414262

Peritogiannis V

2007

Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.

17418386

Sanfilippo JS

2007

Ovarian function--from the beginning.

17418389

Fleischman A

2007

Normal ovarian structure and function with normal glucose tolerance in girls with early treatment of classic congenital adrenal hyperplasia.

17418395

Khan U

2007

Polycystic ovary syndrome in adolescents.

17418832

De Leo V

2007

Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.

17418836

Araujo Penna I

2007

Cardiovascular risk factors are reduced with a low dose of acarbose in obese patients with polycystic ovary syndrome.

17418838

Al-Sunaidi M

2007

Repeated pregnancies and live births after in vitro maturation treatment.

17418849

Charitidou C

2008

The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.

17419299

Bendlov? B

2007

[Study of the genetic causes of polygeneticallv determined endocrinopathies--patience can bring success].

17419303

Vrb?kov? J

2007

[Polycystic ovary syndrome in 2006].

17419309

Duskov? M

2007

[The polycystic ovary syndrome and its male equivalent].

17425825

Hashimoto S

2007

Effect of aspiration vacuum on the developmental competence of immature human oocytes retrieved using a 20-gauge needle.

17425838

Geisth?vel F

2007

The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS)--an extended critical analysis.

17426085

Luque-Ram?rez M

2007

Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.

17426092

Goodarzi MO

2007

Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.

17426408

Harwood K

2007

Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth.

17427503

Szpringer EA

2006

[Polycystic ovary syndrome and hair unit function disturbances in dermatological practice].

17431730

Royston SL

2008

Adverse effects reported in epilatory ruby laser treatment.

17433314

Bloom MS

2007

The use and misuse of matching in case-control studies: the example of polycystic ovary syndrome.

17433315

Bruno RV

2007

Comparison of two doses of metformin (2.5 and 1.5 g/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference.

17433328

Schattmann L

2007

Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women.

17433813

Weghofer A

2007

Lack of association between polycystic ovary syndrome and embryonic aneuploidy.

17435860

Vilar L

2007

[Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].

17435870

Spritzer PM

2007

[Prevalence of metabolic syndrome in patients of south of Brazil with polycystic ovary syndrome (PCOS)].

17436602

Or Y

2006

Ovarian stimulation in polycystic ovarian syndrome.

17437514

Orio F

2007

Lack of electrocardiographic changes in women with polycystic ovary syndrome.

17441487

Bowen-Simpkins P

2007

Detecting polycystic ovary syndrome.

17441890

Vural B

2007

Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?

17441891

Kato M

2007

Efficacy of laparoscopic ovarian drilling for polycystic ovary syndrome resistant to clomiphene citrate.

17441994

Prabhakar S

2007

Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.

17442585

Kimura S

2007

Androgen receptor function in folliculogenesis and its clinical implication in premature ovarian failure.

17445549

Corbould A

2007

The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome.

17445806

Kolibianakis EM

2007

Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.

17449511

Balen A

2007

Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial.

17449514

Dewailly D

2007

The excess in 2-5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome.

17451692

Uncu G

2007

ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.

17451693

Al-Mizyen E

2007

Unilateral laparoscopic ovarian diathermy in infertile women with clomiphene citrate-resistant polycystic ovary syndrome.

17454168

Genazzani AD

2007

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.

17454169

Weerakiet S

2007

Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria.

17454172

Wiltgen D

2007

CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome.

17454173

Finsterer J

2007

Pseudotumor cerebri from sinus venous thrombosis, associated with polycystic ovary syndrome and hereditary hypercoagulability.

17454207

Palep-Singh M

2007

Polycystic ovary syndrome and the single nucleotide polymorphisms of methylenetetrahydrofolate reductase: a pilot observational study.